Free tool
Upcoming earnings calendar
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the US in the next 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
4,096 companies reporting in the next 90 days. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Theme | Market cap (USD) | 1M return | |
|---|---|---|---|---|---|
| Thursday, Nov 5 · in 69 days · 100 companies | |||||
| WTI | W&T Offshore, Inc. | Oil and gas exploration | $538.87M | +12.26% | |
| OLP | One Liberty Properties, Inc. | Industrial reit | $529.55M | −3.63% | |
| CCCC | C4 Therapeutics, Inc. | Oncology | $521.63M | +19.44% | |
| PANL | Pangaea Logistics Solutions Ltd. | Marine shipping | $518.55M | +5.04% | |
| CCOI | |||||
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock. Looking for a name that isn't listed? Jump straight to it:
| Telecom infrastructure |
| $514.72M |
| −22.39% |
| WNC | Wabash National Corporation | Industrial machinery | $509.62M | −6.01% |
| VHI | Valhi, Inc. | Specialty chemicals | $509.50M | +34.85% |
| DNA | Ginkgo Bioworks Holdings, Inc. | Life science tools | $507.75M | −6.10% |
| 0JDK.L | Iovance Biotherapeutics, Inc. | Cell therapy | $501.00M | −2.04% |
| CLPT | ClearPoint Neuro, Inc. | Medical devices | $499.35M | +12.66% |
| PACB | Pacific Biosciences of California, Inc. | Life science tools | $484.90M | +12.23% |
| OCGN | Ocugen, Inc. | Gene therapy | $478.15M | +13.71% |
| LOCO | El Pollo Loco Holdings, Inc. | Fast food and quick service | $475.71M | −3.80% |
| PBYI | Puma Biotechnology, Inc. | Oncology | $472.84M | +14.93% |
| VITL | Vital Farms, Inc. | Packaged foods | $469.67M | −20.84% |
| PRTH | Priority Technology Holdings, Inc. | Payment processing | $462.49M | −18.58% |
| SGHT | Sight Sciences, Inc. | Vision and ophthalmology | $458.33M | +57.92% |
| TWI | Titan International, Inc. | Industrial machinery | $455.02M | −14.44% |
| BIOA | BioAge Labs, Inc. | Neuroscience | $451.63M | −55.11% |
| CARL | Carlsmed, Inc. | Medical devices | $441.76M | +31.44% |
| CMPX | Compass Therapeutics, Inc. | Oncology | $437.61M | +19.12% |
| LRMR | Larimar Therapeutics, Inc. | Rare disease | $432.15M | +8.88% |
| ASPN | Aspen Aerogels, Inc. | EV batteries | $430.71M | +18.22% |
| TRC | Tejon Ranch Co. | Real estate services | $428.83M | −8.27% |
| ADV | Advantage Solutions Inc. | Martech adtech | $420.70M | −19.58% |
| XFOR | X4 Pharmaceuticals, Inc. | Rare disease | $412.45M | +6.11% |
| RCKT | Rocket Pharmaceuticals, Inc. | Gene therapy | $401.78M | +16.56% |
| NATH | Nathan's Famous, Inc. | Fast food and quick service | $400.64M | −1.73% |
| FHTX | Foghorn Therapeutics Inc. | Oncology | $397.29M | +30.41% |
| 0IYQ.L | Gogo Inc. | Telecom infrastructure | $392.11M | +8.43% |
| AIV | Apartment Investment and Management Company | Residential reit | $390.31M | −3.07% |
| TKNO | Alpha Teknova, Inc. | Life science tools | $387.63M | +41.85% |
| GOGO | Gogo Inc. Common Stock | Telecom infrastructure | $386.20M | −29.98% |
| LAND | Gladstone Land Corporation | Specialty reit | $382.62M | +4.60% |
| OPAL | OPAL Fuels Inc. | Biofuels | $380.97M | −2.24% |
| FTW | Presidio Production Company | Oil and gas exploration | $375.24M | +0.18% |
| AGEN | Agenus Inc. | Oncology | $371.33M | +25.00% |
| FNKO | Funko, Inc. | Specialty retail | $357.25M | +0.47% |
| BLND | Blend Labs, Inc. | Fintech software | $350.04M | −16.20% |
| 0XOD.L | UroGen Pharma Ltd. | Oncology | $347.24M | −1.66% |
| TCPC | BlackRock TCP Capital Corp. | Specialty finance | $346.52M | +26.69% |
| NNDM | Nano Dimension Ltd. | Industrial automation | $335.23M | +6.71% |
| RCEL | AVITA Medical, Inc. | Medical devices | $327.52M | +129.72% |
| NL | NLI Holdings, Inc. | Specialty chemicals | $322.24M | +10.76% |
| OBIO | Orchestra BioMed Holdings, Inc. | Medical devices | $316.15M | +36.27% |
| RNAC | Cartesian Therapeutics, Inc. | Cell therapy | $308.30M | +33.20% |
| TMCI | Treace Medical Concepts, Inc. | Medical devices | $306.96M | +17.71% |
| SSP | The E.W. Scripps Company | Streaming media | $304.88M | +2.27% |
| RC | Ready Capital Corporation | Mortgage reit | $304.54M | +26.90% |
| TRDA | Entrada Therapeutics, Inc. | Rare disease | $296.70M | +20.07% |
| KWY | Kingsway Corporation | — | $293.94M | +9.72% |
| NMRA | Neumora Therapeutics, Inc. | Neuroscience | $293.12M | −7.14% |
| KINS | Kingstone Companies, Inc. | Property casualty insurance | $291.84M | −0.15% |
| BKTI | BK Technologies Corporation | Defense electronics | $289.56M | −3.98% |
| ONIT | Onity Group Inc. | Mortgage finance | $288.40M | −14.53% |
| RILY | BRC Group Holdings, Inc. | Investment banking | $285.02M | +5.51% |
| BRT | BRT Apartments Corp. | Residential reit | $284.53M | −3.31% |
| LCTX | Lineage Cell Therapeutics, Inc. | Cell therapy | $283.26M | +4.67% |
| SION | Sionna Therapeutics, Inc. | Rare disease | $282.58M | −86.75% |
| XPOF | Xponential Fitness, Inc. | Travel and leisure | $281.26M | −15.73% |
| WHWK | Whitehawk Therapeutics, Inc. | Oncology | $275.92M | +31.52% |
| RWAY | Runway Growth Finance Corp. | Specialty finance | $273.67M | +18.30% |
| ASLE | AerSale Corporation | Aerospace | $273.47M | −11.85% |
| IVVD | Invivyd, Inc. | Rare disease | $265.78M | +52.06% |
| ALEC | Alector, Inc. | Neuroscience | $263.51M | +61.84% |
| ACRE | Ares Commercial Real Estate Corporation | Mortgage reit | $256.88M | +0.22% |
| HQI | HireQuest, Inc. | Hr tech | $236.97M | +23.44% |
| NUS | Nu Skin Enterprises, Inc. | Beauty and personal care | $236.08M | −7.81% |
| EXFY | Expensify, Inc. | SaaS | $232.53M | +42.46% |
| TBCH | Turtle Beach Corporation | Esports | $229.24M | −1.61% |
| ORGO | Organogenesis Holdings Inc. | Medical devices | $225.18M | −30.83% |
| CHRS | Coherus Oncology, Inc. | Oncology | $224.03M | +0.69% |
| SIGA | SIGA Technologies, Inc. | Rare disease | $220.58M | −8.08% |
| LCUT | Lifetime Brands, Inc. | Household products | $209.89M | +5.12% |
| 0R1C.L | GoPro, Inc. | Computer vision | $208.33M | −2.02% |
| 0ZNF.L | Turtle Beach Corporation | Esports | $204.49M | −1.01% |
| ALTG | Alta Equipment Group Inc. | Industrial machinery | $202.53M | −2.67% |
| CIA | Citizens, Inc. | Life insurance | $197.00M | −22.64% |
| BAFN | BayFirst Financial Corp. | Regional banks | $196.56M | +19.12% |
| AOMR | Angel Oak Mortgage REIT, Inc. | Mortgage reit | $195.93M | −6.80% |
| CDXS | Codexis, Inc. | Contract research cdmo | $180.68M | +10.00% |
| WW | WW International, Inc. | Glp 1 and obesity | $175.98M | +27.91% |
| QSI | Quantum-Si incorporated | Life science tools | $173.05M | +3.89% |
| ONL | Orion Properties Inc. | Commercial office reit | $167.71M | +7.66% |
| USBC | USBC, Inc. | Cryptocurrency and digital assets | $159.68M | +28.56% |
| SITC | SITE Centers Corp. | Retail reit | $159.00M | −11.55% |
| COOK | Traeger, Inc. | Specialty retail | $158.60M | −3.88% |
| GHI | Greystone Housing Impact Investors LP | Mortgage reit | $151.51M | +20.86% |
| INGN | Inogen, Inc. | Medical devices | $147.55M | −13.40% |
| OPRX | OptimizeRx Corporation | Healthtech software | $145.98M | +22.24% |
| CLAR | Clarus Corporation | Apparel and footwear | $142.81M | +12.01% |
| KVHI | KVH Industries, Inc. | Telecom infrastructure | $136.60M | −14.71% |
| AMTX | Aemetis, Inc. | Biofuels | $135.68M | +27.03% |
| BDTX | Black Diamond Therapeutics, Inc. | Oncology | $130.42M | +28.98% |
| APYX | Apyx Medical Corporation | Medical devices | $128.48M | −20.98% |
| 0H8T.L | Aclaris Therapeutics, Inc. | Rare disease | $122.82M | −6.69% |
| JYNT | The Joint Corp. | Hospitals and providers | $120.78M | −1.04% |
| RANI | Rani Therapeutics Holdings, Inc. | Glp 1 and obesity | $118.23M | +2.74% |
| STHO | Star Holdings | Real estate services | $117.26M | +3.19% |
| 0I0X.L | Codexis, Inc. | Life science tools | $116.56M | −3.57% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India). Reporting dates are public estimates and can shift.